-
Biotech in $1.5B Gene-Editing Tech License Deal
A biotechnology company is licensing a gene-editing enzyme to Novartis to create treatments for inherited blood disorders such as sickle cell disease.
-
Gene Therapy Start-Up Gains $38M in Early Funds
A new company developing genetic treatments with a high-capacity engineered virus to deliver its therapeutic payloads is raising $38 million in venture funds.
-
Measuring Machines And Why They Matter
There are a variety of different types of coordinate measuring machines, each with its own advantages and disadvantages.
-
Trial Underway of AI Depression Guidance System
A clinical trial has begun testing a system based on artificial intelligence to help clinicians prescribe personalized care for depression in patients.
-
Infographic – Cyberattacks Rated Top Global Threat
Large majorities of Americans now consider cyberattacks and disinformation online as their main worldwide threats, according to a recent poll.
-
Walgreens to Aid Recruitment for Clinical Trials
A retail drugstore chain is offering its store locations and online facilities to help recruit a more diverse patient population for clinical trials.
-
Digital Biomarkers Reveal Alzheimer’s Gender Differences
A study of people with and without Alzheimer’s disease found differences between women and men in their state of cognitive decline with data from mobile devices.
-
Life Science Investors Raise $1.1B for New Fund
A venture capital company specializing in health and life sciences start-up enterprises is raising $1.1 billion for a new investment fund.
-
Mobile Therapy Shown to Cut Opioid Hospital Care
An analysis of insurance claims shows patients using a mobile therapy app for opioid addiction use fewer hospital services than similar individuals without the app.
-
Companies Partner on Optimal Parkinson’s Drug Delivery
Two companies are developing a system to identify optimal times for people with Parkinson’s disease to take their symptom-reducing medications.